Kolon Life Science Company Description

Kolon Life Science Inc., a biotechnology company, develops cell and gene therapy products.

The company is developing KLS-2031, a product candidate in Phase 1 clinical trials for use in the treatment of neuropathic pain; and KLS-3021, a oncolytic viral therapy in pre-clinical development.

It also provides active pharmaceutical ingredients and pharmaceutical intermediates; offers CDMO and CMO services; and supplies pyrithione antimicrobial for use in personal care and industrials products.

The company was formerly known as Korea Tissuegene Asia, Ltd. and changed its name to Kolon Life Science Inc. in January 2006.

Kolon Life Science Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Kolon Life Science Inc.

Country	South Korea
Founded	2000
Industry	Medicinal Chemicals and Botanical Products
Employees	420
CEO	Sun Jin Kim

Contact Details

Address: One & Only Tower Seoul South Korea
Phone	82 2 3677 4150
Website	kolonls.co.kr

Stock Details

Ticker Symbol	102940
Exchange	KOSDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
ISIN Number	KR7102940004
SIC Code	2833

Key Executives

Name	Position
Sun Jin Kim	Chief Executive Officer
Sang-Jun Lee	Chief Operating Officer